| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| TUDCA | Alzheimer's Disease | 8 | PM | 38440398 | 📋 | Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer's disease |
| TUDCA | Alzheimer's Disease | 3 | PM | 34585224 | 📋 | Tauroursodeoxycholic Acid Attenuates Diet-Induced and Age-Related Peripheral Endoplasmic Reticulum Stress and Cerebral Amyloid Pathology in a Mouse Model of Alzheimer's Disease |
| TUDCA | Alzheimer's Disease | 2 | PM | 34518585 | 📋 | Energy homeostasis deregulation is attenuated by TUDCA treatment in streptozotocin-induced Alzheimer's disease mice model |
| TUDCA | Alzheimer's Disease | 1 | PM | 33321116 | 📋 | The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model |
| TUDCA | Alzheimer's Disease | 7 | PM | 25443293 | 📋 | Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset |
| TUDCA | Alzheimer's Disease | 6 | PM | 22974733 | 📋 | Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice |
| TUDCA | Alzheimer's Disease | 5 | PM | 22621777 | 📋 | Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice |
| TUDCA | Alzheimer's Disease | 4 | PM | 22438081 | 📋 | TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice |
| TUDCA | Amyotrophic Lateral Sclerosis | 5 | PM | 37973672 | 📋 | Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect |
| TUDCA | Amyotrophic Lateral Sclerosis | 2 | PM | 37842553 | 📋 | Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study |
| TUDCA | Amyotrophic Lateral Sclerosis | 1 | PM | 37153676 | 📋 | Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis |
| TUDCA | Amyotrophic Lateral Sclerosis | 4 | PM | 30446391 | 📋 | A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress |
| TUDCA | Amyotrophic Lateral Sclerosis | 3 | PM | 25664595 | 📋 | Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis |
| TUDCA | Familial Adenomatous Polyposis | 1 | PM | 22366264 | 📋 | Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells |
| TUDCA | Osteogenesis Imperfecta | 1 | PM | 28475764 | 📋 | The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta |
| TUDCA | Polycystic Ovary Syndrome | 2 | PM | 32020188 | 📋 | Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS |
| TUDCA | Polycystic Ovary Syndrome | 1 | PM | 30423122 | 📋 | Endoplasmic Reticulum Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS |
| TUDCA | Retinitis Pigmentosa | 1 | PM | 30924157 | 📋 | Disease mechanisms and neuroprotection by tauroursodeoxycholic acid in Rpgr knockout mice |
| TUDCA | Retinitis Pigmentosa | 5 | PM | 26427442 | 📋 | Tauroursodeoxycholic Acid Protects Retinal Function and Structure in rd1 Mice |
| TUDCA | Retinitis Pigmentosa | 4 | PM | 25359524 | 📋 | Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects |
| TUDCA | Retinitis Pigmentosa | 3 | PM | 22110077 | 📋 | TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice |
| TUDCA | Retinitis Pigmentosa | 2 | PM | 21508111 | 📋 | Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats |
